EUVIMEDEUVIMED entdecken
Crossref

Controlled Refolding of Denatured IL‐12 Using In Situ Antigen‐Capturing Nanochaperone Remarkably Reduces the Systemic Toxicity and Enhances Cancer Immunotherapy

Yongxin Zhang, Feihe Ma, Jiajing Chen, Yujie Chen, Linlin Xu, Ang Li, Yang Liu, Rujiang Ma, Linqi Shi iD

Advanced Materials · 2024

DOI: 10.1002/adma.202309927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Yongxin Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Functional Polymer Materials of Ministry of Education, Institute of Polymer Chemistry, State Key Laboratory of Medicinal Chemical B…. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Immunotherapy, Interleukin-12, Nanostructures. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytokines are powerful in cancer immunotherapy, however, their therapeutic potential is limited by the severe systemic toxicity. Here a potent strategy to reduce the toxicity of systemic cytokine therapy by delivering its denatured form using a finely designed nanochaperone, is described. It is demonstrated that even if the denatured protein cargos are occasionally released under normal physiological conditions they are still misfolded, while can effectively refold into native states and release to function in tumor microenvironment. Consequently, the systemic toxicity of cytokines is nearly completely overcome. Moreover, an immunogenic cell death (ICD)‐inducing chemotherapeutic is further loaded and delivered to tumor using this nanochaperone to trigger the release of tumor‐associated antigens (TAAs) that are subsequently captured in situ by nanochaperone and then reflows into lymph nodes (LNs) to promote antigen cross‐presentation. This optimized personalized nanochaperone‐vaccine demonstrates unprecedented suppressive effects against large, advanced tumors, and in combination with immune checkpoint blockade (ICB) therapy results in a significant abscopal effect and inhibition of postoperative tumor recurrence and metastasis. Hence, this approach provides a simple and universal delivery strategy to reduce the systemic toxicities of cytokines, as well as provides a robust personalized cancer vaccination platform, which may find wide applications in cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, NeoplasmImmunotherapyInterleukin-12NanostructuresAnimalsHumansMiceCancer VaccinesCell Line, TumorImmunogenic Cell DeathNanoparticlesNeoplasmsProtein FoldingTumor Microenvironment

Stichwörter der Autor:innen

IL‐12 deliverycancer immunotherapypersonalized nanochaperone‐vaccineprotein refoldingsystemic toxicity

Substanzen

Antigens, NeoplasmCancer VaccinesInterleukin-12

Autor:innen und Institutionen

  • Key Laboratory of Functional Polymer Materials of Ministry of Education, Institute of Polymer Chemistry, State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for New Organic Matter, College of Ch…
  • Haihe Laboratory of Sustainable Chemical Transformations, Tianjin, 300192, P. R. China.

ORCID-Profile: Linqi Shi

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, Y., Ma, F., Chen, J., Chen, Y., Xu, L., Li, A., Liu, Y., Ma, R., & Shi, L. (2024). Controlled Refolding of Denatured IL‐12 Using In Situ Antigen‐Capturing Nanochaperone Remarkably Reduces the Systemic Toxicity and Enhances Cancer Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.202309927

Vancouver

Zhang Y, Ma F, Chen J, Chen Y, Xu L, Li A, et al. Controlled Refolding of Denatured IL‐12 Using In Situ Antigen‐Capturing Nanochaperone Remarkably Reduces the Systemic Toxicity and Enhances Cancer Immunotherapy. Advanced Materials. 2024. doi:10.1002/adma.202309927

BibTeX
@article{Zhang2024,
  author = {Zhang, Yongxin and Ma, Feihe and Chen, Jiajing and Chen, Yujie and Xu, Linlin and Li, Ang and Liu, Yang and Ma, Rujiang and Shi, Linqi},
  title = {Controlled Refolding of Denatured IL‐12 Using In Situ Antigen‐Capturing Nanochaperone Remarkably Reduces the Systemic Toxicity and Enhances Cancer Immunotherapy},
  journal = {Advanced Materials},
  year = {2024},
  doi = {10.1002/adma.202309927}
}
Kostenlos starten →